20K-GH and its use in detecting GH abuse

Growth Hormone and IGF Research

Volumn 19, Issue 4, 2009, Pages 352-356

  Irie, Minoru ^a   Ueki, Makoto ^b   Kishikawa, Yoshifumi ^b   Nishii, Manabu ^b   Kawahara, Takashi ^c  

^a TOHO UNIVERSITY   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c JAPAN INSTITUTE OF SPORTS SCIENCES   (Japan)

Author keywords

20K GH (20K Dalton GH); 22K GH (22K Dalton GH); GH abuse; GH doping test; WADA

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE ANTIBODY; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; ATHLETE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DOPING; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPOLYSIS; NEGATIVE FEEDBACK; NONHUMAN; PERIPHERAL EDEMA; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ATHLETES; CHEMISTRY, CLINICAL; DOPING IN SPORTS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; SUBSTANCE ABUSE DETECTION;

EID: 67651165025     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.04.013     Document Type: Article

References (31)

1. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr. Rev. 12 (1991) 424-449
2. Lewis U.J., Dunn J.T., Bonewald L.F., Seavey B.K., and VanderLaan W.P. A naturally occurring structural variant of human growth hormone. J. Biol. Chem. 253 (1978) 2679-2687
3. Lewis U.J., Bonewald L.F., and Lewis L.J. The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem. Biophys. Res. Commun. 92 (1980) 511-516
4. DeNoto F.M., Moore D.D., and Goodman H.M. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucl. Acids Res. 9 (1981) 3719-3730
5. Uchida H., Naito N., Asada N., Wada M., Ikeda M., Kobayashi H., Asanagi M., Mori K., Fujita Y., Konda K., Kusuhara N., Kamioka T., Nakashima K., and Honjo M. Secretion of authentic 20-kDa human growth hormone (20 K hGH) in Escherichia coli and properties of the purified product. J. Biotechnol. 55 (1997) 101-112
6. Ishikawa M., Tachibana T., Kamioka T., Horikawa R., Katsumata N., and Tanaka T. Comparison of the somatogenic action of 20 KDa- and 22 kDa-human growth hormones in spontaneous dwarf rats. Growth Horm. IGF Res. 10 (2000) 199-206
7. Wang D.S., Sato K., Demura H., Kato Y., Maruo N., and Miyachi Y. Osteo-anabolic effects of human growth hormone with 22 K- and 20 K daltons on human osteoblast-like cells. Endocrine J. 46 (1999) 125-132
8. Asada N., Takahashi Y., Wada M., Naito N., Uchida H., Ikeda M., and Honjo M. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20 K hGH. Mol. Cell. Endocrinol. 162 (2000) 121-129
9. Hayakawa M., Shimazaki Y., Tsushima T., Kato Y., Takano K., Chihara K., Shimatsu A., and Irie M. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical traial of 20K-hGH. J. Clin. Endocrinol. Metab. 89 (2004) 1562-1571
10. Satozawa N., Takezawa K., Miwa T., Takahashi S., Hayakawa M., and Ooka H. Differences in the effects of 20 K- and 22 K-hGH on water retention in rats. Growth Horm. IGF Res. 10 (2000) 187-192
11. Takahashi S., Shiga Y., Satozawa N., and Hayakawa M. Diabetogenic activity of 20KDa human growth hormone (20 K-hGH) and 22 K-hGH in rats. Growth Horm. IGF Res. 11 (2001) 110-116
12. Hashimoto Y., Ikeda I., Ikeda M., Takahashi Y., Hosaka M., Uchida H., Kono N., Fukui H., Makino T., and Honjo M. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone. J. Immunol. Meth. 221 (1998) 77-85
13. Tsushima T., Katoh Y., Miyachi Y., Chihara K., Teramoto A., Irie M., and Hashimoto Y. And study group of 20 K hGH, Serum concentration of 20 K human growth hormone (20 K hGH) measured by a specific enzyme-linked immnosorbent assay. J. Clin. Endocrinol. Metab. 84 (1999) 317-322
14. Asada N., Takahashi Y., Wada M., Naito N., Uchida H., Ikeda M., and Honjo M. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20 K hGH. Mol. Cell. Endocrinol. 162 (2000) 121-129
15. Hashimoto Y., Kamioka T., Hosaka M., Mabushi K., Mizuchi A., Shimazaki Y., Tsunoo M., and Tanaka T. Exogenous 20 K growth hormone (GH) suppresses endogenous 22 K GH secretion in normal men. J. Clin. Endocrinol. Metab. 85 (2000) 601-606
16. Ishikawa M., Yokoya S., Tachibana K., Hasegawa Y., Yasuda T., Tokuhiro E., Hashimoto Y., and Tanaka T. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children. J. Clin. Endocrinol. Metab. 84 (1999) 98-104
17. Fazio S., Sabatini D., Capaldo B., Vigorito C., Giordano A., Guida R., Pardo F., Biondi B., and Sacca L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334 (1996) 809-814
18. Momomura S., Hashimoto Y., Shimazaki Y., and Irie M. Detection of exogenous growth hormone (GH) administration by monitoring raito of 20 kDa- and 22 kDa-GH in serum and urine. Endocrine J. 47 (2000) 97-101
19. M. Ueki, M. Sato, M. Irie, Characterization of isoform selective GH immunoassay system and Japanese perspective of measuring GH isoforms, in: L.D. Bowers, R.L. Hilderbraund, E.J. Symanski (Eds.), Detection of Human Growth Hormone Abuse in Sport, United States Anti-Doping Agency, Colorado, USA, 2005, pp. 86-90.
20. Ueki M., Sato M., and Irie M. Characterization of isoform selective GH immunoassay system and Japanese perspective of measuring GH isoforms. In: Bowers L.D., Hilderbraund R.L., and Symanski E.J. (Eds). Detection of Human Growth Hormone Abuse in Sport (2005), United States Anti-Doping Agency, Colorado, USA 86-90
21. A.E. Nelson, M. Ueki, T.V. Nguyen, K.C. Leung, C.J. Howe, G.J. Trout, M. Irie, R.C. Baxter, D.J. Handelsman, R. Kazlauskas, K.KY. Ho, The influence of demographic factors on the ratio of 20-kDa and 22-kDa GH isoforms and the utility of the ratio for detection of GH doping in sport, in: 3rd International Congress of the GRS and the IGF Society, Kobe, Japan, Growth Horm. IGF Res. 11, Suppl. B (Abstract), 2006, p. S3.
22. A.E. Nelson, The influence of demographic factors and sporting type on markers of GH abuse in elite athletes, in: Satellite Symposium III, The 3rd International Congress of the GRS and IGF Society, Kobe, Tokyo, November 15, 2006 "Use and Abuse of GH" (Abstract), 2006, pp. 25-26,.
23. A.E. Nelson, M. Ueki, U. Meinhardt, G. Stone, I. Walker, J. Hansen, R.C. Baxter, D.J. Handelsman, M. Irie, R. Kazlauskas, K.K. Ho, Detection of GH doping using the ratio of 22 K to 20 K GH isoforms: a double-blind placebo-controlled study, in: presented at The Endocrine Society's 90th Annual Meeting, San Francisco, USA, 2008.
24. Haigh B.W., Lynskey M., Irvin M., Guralski D., Arrigo L., Scott M., and Very Jr. D.L. The development of quantitative multiplexed methods to measure and corroborate the concentration of IGF-1 and P-III-P-NP in human serum. In: Bowers L.D., Hilderbraund R.L., and Symanski E.J. (Eds). Detection of Human Growth Hormone Abuse in Sport (2005), United States Anti-Doping Agency, Colorado, USA 71-74
25. Pang S., Smith J., Onley D., Reeve J., Walker M., and Foy C.A. A comparability study of the emerging protein array platforms with established ELISA procedures. J. Immunol. Methods 302 (2005) 1-12
26. McHugh C.M., Park R.T., Sonksen P.H., and Holt R.I.G. Challenges in detecting the abuse of growth hormone in sport. Clin. Chem. 51 (2005) 1587-1593
27. Wallace J.D., Cuneo R.C., Bidlingmaier M., Lundberg P.A., Carlsson L., Boguszewski C.L., Hay J., Boroujerdi M., Cittadini A., Dall R., Rosen T., and Strasburger C.J. Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. J. Clin. Endocrinol. Metab. 86 (2001) 1731-1737
28. Leung K.C., Howe C., Gui L.Y.Y., Trout G., Veldhuis J.D., and Ho K.K.Y. Physiological and pharmacological regulation of 20-kDa growth hormone. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E836-E843
29. Boguszewski C.L., Hynsjo L., Johannsson G., Bengtsson B.-A., and Carlsson L.M.S. 22-kD growth hormone exclusion assay: a new approach to measurement of non-22-kD growth hormone isoforms in human blood. Eur. J. Endocrinol. 135 (1996) 573-582
30. Wu Z., Bidlingmaier M., Dall R., and Strasburger C.J. Detection of doping with human growth hormone. Lancet 353 (1999) 895
31. Bidlingmaier M., Wu Z., and Strasburger C.J. Test method: GH. Bailliers Best Pract. Res. Clin. Endcronol. Metab. 14 (2000) 99-109